EPHA2 and adenocarcinoma: Blockade of Ephrin B3 or EphA2 expression altered morphology of both adenocarcinoma (AC) H23 cells and large cell/adenocarcinoma (LC/AC) U-1810 cells while no effect was seen in squamous cell (SQ) U-1752 (Figure 1B).